Back to search

Article

XRCC4 glutarylation increases sensitivity to PARP inhibitors in breast cancer by inhibiting mTOR activity and promoting autophagy

2026-06-08

Abstract excerpt

<title>Abstract</title> <p> Background Glutarylation, a newly identified form of protein acylation, has been linked to the regulation of tumor metabolism. However, the role of glutarylation in breast cancer is currently unclear. Methods Multi-omics datasets analysis was employed to delineate the characteristics of XRCC4 in breast cancer. The roles of XRCC4 in breast cancer were validated using CCK-8, EdU, and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4967b03-4d95-540f-a251-1f24740337c6
DOI
10.21203/rs.3.rs-9924119/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
XRCC4 glutarylation increases sensitivity to PARP inhibitors in breast cancer by inhibiting mTOR activity and promoting autophagyDOI 10.21203/rs.3.rs-9924119/v1
Select a neighboring publication to make it the new centre.